Soluble intercellular adhesion molecule—1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenografts

This publication has 13 references indexed in Scilit:

• Circulating adhesion molecules in disease
  Immunology Today, 1993
• Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological Significance
  Annals of the New York Academy of Sciences, 1992
• Heterogeneous susceptibility of human melanoma clones to monocyte cytotoxicity: Role of ICAM‐1 defined by antibody blocking and gene transfer
  European Journal of Immunology, 1992
• Circulating Intercellular Adhesion Molecule-1 in Melanoma Patients: Induction by Interleukin-2 Therapy
  Journal of Immunotherapy, 1992
• Anti‐tumor and immunomodulatory activity of intraperitoneal IFN‐γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy
  International Journal of Cancer, 1992
• Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases
  Clinical and Experimental Immunology, 1991
• Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice
  Clinical & Experimental Metastasis, 1991
• Increased susceptibility of ifn-γ-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: Participation of ICAM-1 induction on target cells
  International Journal of Cancer, 1991
• Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy
  International Journal of Cancer, 1989
• Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells.
  The Journal of cell biology, 1988